Contra-indicated in patients with a history of bowel obstruction, with serum triglyceride concentrations >500 mg/dL or with a history of hypertriglyceridemia-induced pancreatitis.
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAMES: Cholestagel (Genzyme); Welchol (Sankyo)
- INDICATIONS: Hypercholesterolemia, hyperlipidemia, Type II diabetes mellitus
- CLASS: Bile acid sequestrant
- HALF-LIFE: N/A
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Cyclosporine, Deferasirox, Estradiol, Glyburide, Levothyroxine, Olmesartan, Phenytoin, Warfarin
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of colesevelam in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 07/31/2023
